Not so quiet for AstraZeneca at the ATS, they presented 60 Abstracts
with data highlighting breakthrough science on the causes of respiratory disease.
AZ are focusing on 4 key areas
1. Eosinophillic disease ( just successful completed phase 3 severe asthma with a drug called benralizumab )
2. Th2 disease
3. Epithelial driven pathiology !!
4. Autoimmunity
I can't believe they wouldn't be interested in their former employees work to date.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.015(12.0%) |
Mkt cap ! $9.320M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 11.0¢ | $10.27K | 86.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3577 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 85917 | 1 |
View Market Depth
| Last trade - 12.34pm 25/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |